1-3 of 3
Julie Fitzgerald
Close
Sort by
Journal Articles

Biomarkers Accurately Predict Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Acute Lymphoblastic Leukemia (ALL)

David T Teachey, MD, Simon F. Lacey, PhD BSc, Pamela A Shaw, PhD, J Joseph Melenhorst, PhD, Noelle V. Frey, MD, Shannon L Maude, MD PhD, David M. Barrett, MD PhD, Richard Aplenc, MD PhD, Fang Chen, PhD, Julie Fitzgerald, MD PhD, Vanessa Gonzalez, M.B.A, Edward Pequignot, PhD, Susan R. Rheingold, MD, Scott Weiss, MD, Jason C. White, DO, Carl H. June, MD, David L. Porter, MD, Stephan A. Grupp, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1334.
https://doi.org/10.1182/blood.V126.23.1334.1334
Published: 2015
Journal Articles

Treatment Toxicity and Supportive Care Utilization in Children with Down Syndrome and Acute Lymphoid Leukemia at Free-Standing Pediatric Hospitals in the United States

Elizabeth K Goodman, AB, Yimei Li, PhD, Alix E. Seif, MD MPH, Julie Fitzgerald, MD PhD, Yuan-Shung Huang, MS, Rochelle Bagatell, MD, Brian T. Fisher, DO, MSCE, Richard Aplenc, MD PhD
Journal: Blood
Blood (2014) 124 (21): 553.
https://doi.org/10.1182/blood.V124.21.553.553
Published: 2014
Journal Articles

Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene

Denise E. Sabatino, Elina Armstrong, Shyrie Edmonson, Yi-Lin Liu, Marc Pleimes, Joerg Schuettrumpf, Julie Fitzgerald, Roland W. Herzog, Valder R. Arruda, Katherine A. High
Journal: Blood
Blood (2004) 104 (9): 2767–2774.
https://doi.org/10.1182/blood-2004-03-1028
Published: 2004